Bharat Book Bureau: Analgesics in Australia
(M2 PressWIRE Via Acquire Media NewsEdge) Arthritis was a key driver of sales within analgesics in 2012. A report by Access Economics found that 3.85 million Australians suffer with a form of arthritis, with the figure expected to double by 2050. With Australians worried about developing arthritis more than any other disease, brand operators have focused on developing more effective products for the relief of arthritic pain. For example Panadol Osteo from GlaxoSmithKline Australia Pty Ltd is positioned and designed to treat arthritic...
Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/analgesics-in-australia1.html
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Call UK +44 7405 208461
Follow us on twitter: https://twitter.com/researchbook
Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/
For Live Chat - http://bit.ly/19m3TU4
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to email@example.com)).
(c) 2013 M2 COMMUNICATIONS
[ Back To Technology News's Homepage ]